Agenus reported $-46434000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Agenus AGEN:US $ -46.43M 1.89M
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 360M 26M
Bristol Myers Squibb BMY:US $ 1421M 143M
Celldex Therapeutics CLDX:US $ -36M 12.95M
Chemocentryx CCXI:US $ -31.65M 6.96M
CSL CSL:AU $ 1.76B 1.2B
Dynavax Technologies DVAX:US $ 128.76M 95.9M
Eli Lilly And LLY:US $ 952.5M 950.4M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Glaxosmithkline GSK:US $ 838M 964M
Immunogen IMGN:US $ -62.02M 37.88M
Jiangsu Hengrui Me. 600276:CH CH 1.24B 913.93M
Johnson & Johnson JNJ:US $ 4814M 335M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Merck MRK:GR € 867M 14M
Merk MRK:US $ 3944M 366M
Northwest Biotherapeutics NWBO:US -14214000 147.53M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Veracyte VCYT:US $ -9.53M 4.93M
YTE INCY:US $ 161.43M 123.44M